Search Results for "Reminder Sample Letter Prostate Cancer"

08:49 EDT 5th October 2015 | BioPortfolio

Matching Channels

Prostate Cancer in Men

Prostate cancer is the most common cancer in men in the UK; affecting 250,000 men. Risk factors for prostate cancer include age (average age at diagnosis is 70), a family history and a Caribbean or ...

Prostate Cancer Cellular Vaccine rDNA

Prostate specific membrane antigen PSMA

Prostate-specific membrane antigen (PSMA) is a transmembrane protein commonly found on the surface of late-stage and metastatic prostate cancer and a well-known imaging biomarker for staging and monit...

Abiraterone Acetate - Zytiga

On April 28, 2011, the US Food and Drug Administration (FDA) approved Zytiga (abiraterone acetate), for use in combination with prednisone for the second-line treatment of castration-resistant prost...

Prostate Mab

Matching News

Genetics of Prostate Cancer–for health professionals (PDQ®)

SOURCE April 2015 SECTIONS Introduction Identifying Genes and Inherited Variants Associated With Prostate Cancer Risk Genes With Potential Clinical Relevance in Prostate Cancer Risk Interventions in F...

Cancer biology: Studying a new subtype of prostate cancer

A better understanding of a common gene mutation in prostate cancer cells may lead to novel strategies for combating lethal prostate cancer

Link Found Between Breast-Cancer Genes, Prostate Cancer

A man receives a medical scan to check for prostate cancer. PHOTO: GETTY IMAGES SOURCE Study finds BRCA1 or BRCA2 mutations in prostate-cancer patients Mutations in two genes well known for increasing...

Prostate cancer: Intrapatient heterogeneity in prostate cancer

A newly published study used whole-genome sequencing of multiple prostate tumour foci from several patients with intermediate-risk prostate cancer to track evolutionary patterns and delineate the mark...

Which Diet Confers the Most Benefit in Prostate Cancer?

Gerald Chodak comments on a study looking at the diets of men diagnosed with prostate cancer. Can diet lower the mortality rate of men with prostate cancer? Medscape Urology

Genetic alterations associated with risk of prostate cancer

22 genetic variations that are associated with an increased risk of developing prostate cancer have been identified by an international team of researchers. Prostate cancer affects one out of every 6 ...

UH Seidman Cancer Center performs first-ever prostate cancer treatment

(University Hospitals Case Medical Center) The radiation oncology team at UH Seidman Cancer Center in Cleveland performed the first-ever prostate cancer treatment April 3 using a newly-approved device...

New Tool for Guiding Therapy in Prostate Cancer Patients

Researchers at the University of Central Florida say they have now come up with a $1 test using gold nanoparticles that can outperform PSA (prostate specific antigen) screening for prostate cancer.

Matching PubMed Articles

Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.

We previously found that inflammation in benign prostate tissue is associated with an increased odds of prostate cancer, especially higher-grade disease. Since part of this link may be due to genetics...

Testosterone replacement therapy and prostate cancer: the downfall of a paradigm?

For six decades, it has been a part of the conventional medical wisdom that higher levels of testosterone increase the risk of prostate cancer. This belief is mostly derived from the well-documented r...

Finasteride Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial.

In the Prostate Cancer Prevention Trial (PCPT), finasteride reduced the risk of prostate cancer by 25%, even though high-grade prostate cancer was more common in the finasteride group. However, it rem...

The heritability of prostate cancer-letter.

High Progesterone Receptor Expression in Prostate Cancer Is Associated with Clinical Failure.

Prostate cancer is a highly heterogeneous disease and one of the leading causes of mortality in developed countries. Specific prognostic and predictive markers for prostate cancer patients are still l...

Search Whole site using Google


Advertisement Advertisement